Filing Details
- Accession Number:
- 0001179110-17-009852
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-30 18:19:36
- Reporting Period:
- 2017-06-28
- Filing Date:
- 2017-06-30
- Accepted Time:
- 2017-06-30 18:19:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597264 | Blueprint Medicines Corp | BPMC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1177082 | Daniel Lynch | C/O Blueprint Medicines Corporation 38 Sidney Street, Suite 200 Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-06-28 | 7,901 | $51.17 | 243,941 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-28 | 21,474 | $50.12 | 222,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-28 | 3,125 | $49.09 | 219,342 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.54 to $51.53 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4.
- On May 23, 2017, Third Rock Ventures II, L.P. distributed 1,723 shares to the Reporting Person through an in-kind, pro rata distribution without value. This distribution was exempt from Section 16 of the Exchange Act pursuant to Rules 16a-9 and 16a-13.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.68 to $50.53 per share.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.87 to $49.35 per share.
Billionaire Hedge Funds
